Literature DB >> 8504468

Induction of mutations in mouse FM3A cells by treatment with riboflavin plus visible light and its possible relation with formation of 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in DNA.

T Bessho1, K Tano, S Nishmura, H Kasai.   

Abstract

Photosensitized formation of 8-hydroxyguanine (oh8Gua; 7,8-dihydro-8-oxoguanine, oxo8Gua) in cellular DNA and its repair was examined in mouse FM3A cells. oh8Gua was generated 7-fold above the background level by 10 min irradiation with visible light in the presence of riboflavin (160 microM0 and repaired to 60-70% of initial level after 2 h post-incubation. By this treatment, mutation frequency that was measured by counting ouabain-resistant colonies, was increased 7-fold above the background frequency. The accumulation of unrepaired oh8Gua in DNA generated by treatment with riboflavin plus visible light correlates to induction of mutations. Thus, oh8Gua will contribute to the mutation induced by visible light as well as spontaneous mutations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504468     DOI: 10.1093/carcin/14.5.1069

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

Review 1.  Formation and repair of oxidatively generated damage in cellular DNA.

Authors:  Jean Cadet; Kelvin J A Davies; Marisa Hg Medeiros; Paolo Di Mascio; J Richard Wagner
Journal:  Free Radic Biol Med       Date:  2017-01-02       Impact factor: 7.376

2.  Expression of the E. coli fpg gene in mammalian cells reduces the mutagenicity of gamma-rays.

Authors:  F Laval
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

3.  Lack of direct involvement of 8-hydroxy-2'-deoxyguanosine in hypoxanthine-guanine phosphoribosyltransferase mutagenesis in V79 cells treated with N,N'-bis(2-hydroxyperoxy-2-methoxyethyl)-1,4,5,8-naphthalenetetracarboxylic-diimide (NP-III) or riboflavin.

Authors:  Madoka Nakajima; Toru Takeuchi; Keiki Ogino; Kanehisa Morimoto
Journal:  Jpn J Cancer Res       Date:  2002-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.